In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...